JUNCTURE WEALTH STRATEGIES, LLC
Position in PTCT — Ptc Therapeutics, Inc.
CIK 1632866
SCOTTSDALE, AZ
Position in PTCT
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$862,765
+$512,032 QoQ
Shares Held
10,577
+105.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#36
of 125 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JUNCTURE WEALTH STRATEGIES, LLC holds $4,939,567 across 9 Biotechnology names. PTCT ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
11,865 | $928,673 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
This page
|
10,577 | $862,765 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
34,232 | $580,917 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
18,408 | $578,563 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
4,815 | $563,692 | |
| 6 | INCY |
Incyte Corp
|
4,956 | $561,812 | |
| 7 | VCEL |
Vericel Corp
|
8,283 | $368,510 | |
| 8 | TBPH |
Theravance Biopharma, Inc.
|
17,234 | $292,978 |
All Filings in PTCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $862,765 | 10,577 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $350,733 | 5,148 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $354,961 | 4,673 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $251,739 | 4,102 | Shares | Sole | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||